CytoDyn (CYDY) Shares Outstanding (2010 - 2026)
CytoDyn (CYDY) Shares Outstanding (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 62.06 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 198.10 Mn |
| 10 | CytoDyn | 248.66 Mn | 248.66 Mn | - | 1.28 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 1.28 Bn |
| Nov 30, 2025 | 1.26 Bn |
| Aug 31, 2025 | 1.25 Bn |
| May 31, 2025 | 1.21 Bn |
| Feb 28, 2025 | 1.23 Bn |
| Nov 30, 2024 | 1.22 Bn |
| Aug 31, 2024 | 1.14 Bn |
| May 31, 2024 | 969.51 Mn |
| Feb 29, 2024 | 982.21 Mn |
| Nov 30, 2023 | 958.99 Mn |
| Aug 31, 2023 | 923.59 Mn |
| May 31, 2023 | 836.53 Mn |
| Feb 28, 2023 | 832.22 Mn |
| Nov 30, 2022 | 813.37 Mn |
| Aug 31, 2022 | 787.86 Mn |
| May 31, 2022 | 676.90 Mn |
| Feb 28, 2022 | 695,614.00 |
| Nov 30, 2021 | 662.60 Mn |
| Aug 31, 2021 | 632.60 Mn |
| May 31, 2021 | 587.59 Mn |